Ditchcarbon
  • Contact
  1. Organizations
  2. Dishman Carbogen Amcis
Public Profile
Pharmaceutical Preparation Manufacturing
IN
updated 2 months ago

Dishman Carbogen Amcis Sustainability Profile

Company website

Dishman Carbogen Amcis, a prominent player in the pharmaceutical and biotechnology sectors, is headquartered in India. Founded in 1983, the company has established itself as a leader in contract research and manufacturing services, with a strong presence in Europe, North America, and Asia. Specialising in custom synthesis, active pharmaceutical ingredients (APIs), and drug development services, Dishman Carbogen Amcis is recognised for its innovative approach and commitment to quality. The company’s state-of-the-art facilities and expertise in complex chemistry set it apart in a competitive market. With a focus on sustainability and regulatory compliance, Dishman Carbogen Amcis has achieved significant milestones, including successful collaborations with major pharmaceutical companies. Its dedication to excellence has solidified its position as a trusted partner in the global pharmaceutical landscape.

DitchCarbon Score

How does Dishman Carbogen Amcis's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Dishman Carbogen Amcis's score of 26 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.

42%

Let us know if this data was useful to you

Dishman Carbogen Amcis's reported carbon emissions

In 2024, Dishman Carbogen Amcis reported total carbon emissions of approximately 58,157,000 kg CO2e for Scope 1 and about 17,725,920 kg CO2e for Scope 2. This marks a decrease from 2023, where emissions were approximately 68,113,600 kg CO2e for Scope 1 and about 15,700,600 kg CO2e for Scope 2. The company has disclosed emissions data for both Scope 1 and Scope 2 but has not reported any Scope 3 emissions. Despite the significant emissions figures, there are currently no specific reduction targets or climate pledges outlined by Dishman Carbogen Amcis. The data reported is cascaded from the parent company, Dishman Carbogen Amcis Limited, indicating a corporate family relationship that influences their emissions reporting. The company’s emissions intensity metrics indicate a total Scope 1 and Scope 2 emission intensity of approximately 5.73 kg CO2e per rupee of turnover adjusted for Purchasing Power Parity (PPP) in 2024, and 4.90 kg CO2e per rupee in 2023. In terms of physical output, the emissions intensity was about 88.0 kg CO2e per tonne in 2024, down from 62.0 kg CO2e per tonne in 2023. Overall, while Dishman Carbogen Amcis has made strides in reducing its emissions year-on-year, the absence of formal reduction targets suggests an opportunity for further commitment to climate action.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202220232024
Scope 1
48,975,800
00,000,000
00,000,000
Scope 2
17,489,600
00,000,000
00,000,000
Scope 3
-
-
-

How Carbon Intensive is Dishman Carbogen Amcis's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Dishman Carbogen Amcis's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Dishman Carbogen Amcis's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Dishman Carbogen Amcis is in IN, which has a very high grid carbon intensity relative to other regions.

Dishman Carbogen Amcis's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Dishman Carbogen Amcis has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Dishman Carbogen Amcis's Emissions with Industry Peers

Hikma Pharmaceuticals

GB
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Samsung Biologics

KR
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Aurobindo Pharma

IN
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Aarti Industries

IN
•
Chemicals nec
Updated 3 days ago

Wuxi Apptec

CN
•
Research and development services (73)
Updated 3 days ago

Siegfried Holding

CH
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251112.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
AWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy